KSAT 12: Infectious disease specialist answers your COVID-19 questions
August 14, 2020
Dr. Ruth Berggren, Infectious Diseases, answers viewers’ questions about face shields, vaccines, COVID-19 testing during this Q&A. Read and watch the story.
Newsweek: Child coronavirus cases spiked by 90 percent. It’s likely down to two key reasons
August 13, 2020
Dr. Alvaro Moreira, Pediatrics, spoke to Newsweek about the possible causes of the summertime spike in COVID-19 cases in children: one, children must provide proof they are coronavirus-free before they can attend summer camps and daycare centers and, two, families may be seeking tests reacting to news of a dangerous and life-threatening complication of COVID-19 […]
WQAD TV: Using tree bark to attack tumors
August 13, 2020
WQAD, a television station in Moline, Ill., aired the Ivanhoe Broadcast News story about research conducted by Darpan Patel, PhD, associate professor of research in the School of Nursing, and Pratap Kumar, PhD, from the Department of Molecular Medicine. The researchers decided to test cork tree bark extract, also called Nexrutine, to fight dangerous body […]
Texas Public Radio: Masks, myths, morbidity: Experts answer your COVID-19 questions
August 13, 2020
Dr. Jan Patterson, Infectious Diseases, was a guest on Texas Public Radio’s “The Source” answering various questions about COVID-19 including topics such as vaccine development, masking, myths and morbidity. Listen to the interview.
Oncology Nursing News: Expert offers ways to reduce disparities in cancer clinical trials
August 13, 2020
Dr. Ruben Mesa, MD, director of the Mays Cancer Center, says racial and ethnic disparities in cancer clinical trials impact diagnostics and treatment of minority populations and explains the importance of diversity in clinical trials. Read the story.
OncLive: Mesa sheds light on strategies to combat racial/ethnic disparities in cancer clinical trials
August 13, 2020
Dr. Ruben Mesa, MD, director of the Mays Cancer Center, discusses the racial and ethnic disparities in cancer clinical trials and the efforts being made to increase diversity in clinical trials. Read the story.